RG
NXTM

Redmile Group’s NxStage Medical Inc. NXTM Stock Holding History

Redmile Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-657,356
Closed -$16.5M – 77
2017
Q2 		$16.5M Buy
+657,356
New +$16.3M 1% 37
2015
Q4 		– Sell
-11,800
Closed -$186K – 72
2015
Q3 		$186K Buy
+11,800
New +$189K 0.01% 58
2014
Q2 		– Sell
-1,090,428
Closed -$13.9M – 66
2014
Q1 		$13.9M Buy
1,090,428
+399,658
+58% +$5.21M 1.66% 28
2013
Q4 		$6.91M Buy
+690,770
New +$7.84M 0.85% 42

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Redmile Group's NXTM Position: Q3 2017 in Review

Redmile Group sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 657,356 shares — an estimated $16.5M sold.

Redmile Group first reported a position in NXTM in Q4 2013 and held it in 4 quarters. The position peaked at $16.5M in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Redmile Group reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Redmile Group sold 657,356 NxStage Medical Inc. shares in Q3 2017, an estimated $16.5M.
  • Redmile Group first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 4 quarters.
  • Redmile Group's NxStage Medical Inc. position peaked at $16.5M in Q2 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Redmile Group's 13F filing for Q3 2017, filed 14 Nov 2017.